Nieuwsfeed
- Vaccines and Related Biological Products Advisory Committee June 28, 2022 Meeting Announcement - 06/28/2022
- Vaccines and Related Biological Products Advisory Committee June 14-15, 2022 Meeting Announcement - 06/14/2022
- Vaccines and Related Biological Products Advisory Committee June 7, 2022 Meeting Announcement - 06/07/2022
- UltraQual HIV-1 RT-PCR Assay
- IVDR implementation day overshadowed by lack of notified bodies, risks to patients
- ABBOTT HTLV-I/HTLV-II EIA
- Euro Convergence: SSCP expert lists common mistakes device manufacturers make
- 2022 Meeting Materials, Vaccines and Related Biological Products Advisory Committee
- FDA Flexibilities, Collaboration to Yield Millions of Bottles of Specialized Medical Infant Formula in Coming Months to Increase U.S. Supply
- ABBOTT PRISM HTLV-I/HTLV-II
- Workshops, Meetings & Conferences (Biologics)
- Carimune NF, Nanofiltered
- Flebogamma DIF 5% & 10%
- Annual Patient Engagement & Regenerative Medicine Meeting 2022: An FDA CBER Workshop for Patient Advocates - 05/24/2022
- Vivaglobin
- Anascorp
- Pair of ex-HHS counsels criticize bill to 'upend' 180-day exclusivity for first generic drugs
- Pile-on over PBMs continues with FTC comments and a new bipartisan Senate bill
- Influenza Virus Vaccine, H5N1 (for National Stockpile)
- Bristol Myers Squibb refreshes Eliquis campaign, adds eye-catching animations in TV ads
- Pharma brands fade in annual Harris consumer visibility poll: Moderna drops off and Pfizer dips
- HHS finishes off Trump-era rule that would've erased basic FDA regs without frequent reviews
- Euro Roundup: EMA moves to suspend 100 generic drugs over ‘flawed studies’ run by Indian CRO
- Recon: Lawmakers grill Califf on response to infant formula crisis; Supply chain, China lockdowns cloud Medtronic’s outlook
- Updated Guidance on Clinical Trials for Antimicrobials
- FDA in the Multiverse of 180-Day Exclusivity Madness: Is an “Incursion” in the Cards for our “Exclusivity Earth-616”?
- CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19
- Servier expands Tibsovo label with first combination OK in a rare form of AML
- Biohaven’s zavegepant nasal spray set to reach projected worth of $206.8m in 2030
- Sequoia China leads $37M infusion into radiopharmaceuticals player setting up shop in China and Belgium,
- Biotech SPAC takes IPO goal down a notch; Africa’s top health agency warns against monkeypox vaccine hoarding
- What’s New for Biologics
- Two years post-stealth exit, highly secretive inflammation biotech secures final tranche of Series A round
- In search of elusive NASH breakthrough, Pfizer spotlights combo approach
- Longtime Kadmon consultant slapped with insider trading charges related to $1.9B Sanofi buyout
- Saying goodbye to R&D chief, Flagship-backed Axcella drops PhII program as it focuses on long Covid, NASH
- Manufacturing roundup: Pharmaron secures acquisition of a former Rhode Island facility; GSK to open hub in South America
- Covid-19 roundup: NRx's med gets axed from NIH trial over futility; A new drug for the pandemic enters the clinic
- Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion
- Harbour BioMed concludes first patient dosing in Phase I antibody trial
- Oncotelic to commence Phase II mesothelioma combination therapy trial
- OUT NOW: UNICEF Innocenti's Report Card 17: Places and Spaces
- FY 2019 Report from the Director
- Coronavirus (COVID-19) vaccines adverse reactions
- Sharing Economy: Technology trends
- New safety warnings on risk of insulin leakage from Roche Accu-Chek Insight Insulin pumps
- Class 4 Medicines Defect Information: Orifarm UK Ltd, Loprazolam 1mg Tablets, EL (22)A/25
- Former Editas CEO Katrine Bosley goes the VC route, joining early-stage investor
- National Patient Safety Alert: NovoRapid PumpCart in the Roche Accu-Chek Insight insulin pump: risk of insulin leakage causing hyperglycaemia and diabetic ketoacidosis (NatPSA/2022/004/MHRA)
- LA biotech founder arrested, charged in murder-for-hire scheme behind 2018 death